Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2010 68
2011 74
2012 94
2013 151
2014 160
2015 149
2016 143
2017 148
2018 142
2019 137
2020 185
2021 159
2022 153
2023 126
2024 104

Text availability

Article attribute

Article type

Publication date

Search Results

1,607 results

Results by year

Filters applied: . Clear all
Page 1
Defining quality in thyroid FNA.
Renshaw AA. Renshaw AA. Cancer Cytopathol. 2022 Apr;130(4):246-247. doi: 10.1002/cncy.22541. Epub 2021 Dec 28. Cancer Cytopathol. 2022. PMID: 34962715 Free article. No abstract available.
Deep learning of breast papillary lesions.
Vielh P. Vielh P. Cancer Cytopathol. 2021 Aug;129(8):577-578. doi: 10.1002/cncy.22411. Epub 2021 Feb 9. Cancer Cytopathol. 2021. PMID: 33561297 Free article. No abstract available.
Improving the Pap test with artificial intelligence.
Pantanowitz L. Pantanowitz L. Cancer Cytopathol. 2022 Jun;130(6):402-404. doi: 10.1002/cncy.22561. Epub 2022 Mar 15. Cancer Cytopathol. 2022. PMID: 35291050 Free article. No abstract available.
Editorial in response to Thangaiah et al.
Zhang ML. Zhang ML. Cancer Cytopathol. 2023 Jun;131(6):349-350. doi: 10.1002/cncy.22689. Epub 2023 Mar 1. Cancer Cytopathol. 2023. PMID: 36859762 Free article. No abstract available.
Innovations: Virtual Pathology Recruitment.
Jiang XS, Madrigal E. Jiang XS, et al. Cancer Cytopathol. 2023 Apr;131(4):213. doi: 10.1002/cncy.22651. Epub 2022 Oct 4. Cancer Cytopathol. 2023. PMID: 36194509 Free article. No abstract available.
Recruiting the future of pathology.
LeGallo RD, Atkins KA. LeGallo RD, et al. Cancer Cytopathol. 2022 Aug;130(8):576-578. doi: 10.1002/cncy.22606. Epub 2022 Jun 9. Cancer Cytopathol. 2022. PMID: 35679145 Free PMC article. No abstract available.
Diagnostic mesothelioma biomarkers in effusion cytology.
Eccher A, Girolami I, Lucenteforte E, Troncone G, Scarpa A, Pantanowitz L. Eccher A, et al. Cancer Cytopathol. 2021 Jul;129(7):506-516. doi: 10.1002/cncy.22398. Epub 2021 Jan 19. Cancer Cytopathol. 2021. PMID: 33465294 Free article. Review.
Spotlight: Rising Stars in Cytology.
Lubin D. Lubin D. Cancer Cytopathol. 2022 Oct;130(10):756-757. doi: 10.1002/cncy.22619. Epub 2022 Jul 14. Cancer Cytopathol. 2022. PMID: 35833882 Free article. No abstract available.
Spotlight: Rising stars in cytology.
Torous VF. Torous VF. Cancer Cytopathol. 2022 Aug;130(8):574-575. doi: 10.1002/cncy.22591. Epub 2022 Jun 1. Cancer Cytopathol. 2022. PMID: 35647729 Free article. No abstract available.
CDKN2A/p16 evaluation in cytology specimens.
Xing J, Griffith CC. Xing J, et al. Cancer Cytopathol. 2023 Nov;131(11):672-676. doi: 10.1002/cncy.22701. Epub 2023 Apr 17. Cancer Cytopathol. 2023. PMID: 37068112 No abstract available.
1,607 results